tiprankstipranks
Trending News
More News >
Arterra Bioscience SpA (IT:ARBS)
:ARBS
Italy Market

Arterra Bioscience SpA (ARBS) Ratios

Compare
0 Followers

Arterra Bioscience SpA Ratios

IT:ARBS's free cash flow for Q2 2024 was €0.55. For the 2024 fiscal year, IT:ARBS's free cash flow was decreased by € and operating cash flow was €0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
11.18 11.18 12.08 11.85 6.13
Quick Ratio
9.86 9.86 11.39 10.95 5.76
Cash Ratio
5.01 5.01 6.85 7.23 4.06
Solvency Ratio
0.93 0.93 0.76 0.70 0.47
Operating Cash Flow Ratio
1.59 1.59 1.99 0.76 1.51
Short-Term Operating Cash Flow Coverage
8.01 8.01 6.26 2.21 8.13
Net Current Asset Value
€ 6.08M€ 7.70M€ 6.38M€ 5.30M€ 4.60M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.04 0.05 0.08 0.10
Debt-to-Equity Ratio
0.05 0.05 0.06 0.10 0.14
Debt-to-Capital Ratio
0.04 0.04 0.06 0.09 0.12
Long-Term Debt-to-Capital Ratio
0.03 0.03 0.04 0.07 0.10
Financial Leverage Ratio
1.20 1.20 1.22 1.26 1.34
Debt Service Coverage Ratio
9.62 9.62 6.93 6.49 5.12
Interest Coverage Ratio
48.60 48.60 59.26 -9.72 11.87
Debt to Market Cap
0.03 0.03 0.03 0.04 0.04
Interest Debt Per Share
0.07 0.07 0.09 0.13 0.15
Net Debt to EBITDA
-1.79 -1.83 -2.38 -2.33 -2.97
Profitability Margins
Gross Profit Margin
13.83%13.83%17.60%1.09%11.99%
EBIT Margin
50.65%50.65%33.45%43.05%35.15%
EBITDA Margin
59.84%59.84%46.18%56.77%45.62%
Operating Profit Margin
10.24%10.24%12.64%-5.31%5.21%
Pretax Profit Margin
50.44%50.44%33.23%42.08%34.25%
Net Profit Margin
39.68%39.68%29.03%39.29%31.64%
Continuous Operations Profit Margin
39.68%39.68%29.03%39.29%31.64%
Net Income Per EBT
78.67%78.67%87.36%93.38%92.37%
EBT Per EBIT
492.41%492.41%262.98%-791.77%657.80%
Return on Assets (ROA)
8.57%11.25%9.59%10.74%8.97%
Return on Equity (ROE)
10.01%13.51%11.72%13.55%12.06%
Return on Capital Employed (ROCE)
-13.10%3.12%4.44%-1.55%1.68%
Return on Invested Capital (ROIC)
-10.74%2.45%3.79%-1.40%1.50%
Return on Tangible Assets
8.60%11.29%9.70%11.36%9.69%
Earnings Yield
9.74%9.83%5.75%5.94%3.46%
Efficiency Ratios
Receivables Turnover
1.34 1.34 1.20 0.00 1.39
Payables Turnover
16.35 16.35 12.60 14.83 4.77
Inventory Turnover
2.65 2.65 6.46 4.90 5.61
Fixed Asset Turnover
2.32 2.32 2.30 2.02 2.12
Asset Turnover
0.28 0.28 0.33 0.27 0.28
Working Capital Turnover Ratio
0.43 0.43 0.52 0.44 0.63
Cash Conversion Cycle
490.96 387.40 331.84 49.88 250.67
Days of Sales Outstanding
219.28 272.18 304.34 0.00 262.08
Days of Inventory Outstanding
332.98 137.54 56.47 74.49 65.09
Days of Payables Outstanding
61.29 22.32 28.97 24.62 76.50
Operating Cycle
552.25 409.73 360.81 74.49 327.17
Cash Flow Ratios
Operating Cash Flow Per Share
0.21 0.21 0.21 0.07 0.27
Free Cash Flow Per Share
0.19 0.19 0.12 0.01 0.02
CapEx Per Share
0.01 0.01 0.09 0.06 0.25
Free Cash Flow to Operating Cash Flow
0.93 0.93 0.56 0.20 0.07
Dividend Paid and CapEx Coverage Ratio
14.10 14.10 2.29 0.97 0.91
Capital Expenditure Coverage Ratio
14.10 14.10 2.29 1.25 1.08
Operating Cash Flow Coverage Ratio
2.85 2.85 2.27 0.59 1.73
Operating Cash Flow to Sales Ratio
0.39 0.39 0.37 0.17 0.64
Free Cash Flow Yield
8.53%9.01%4.08%0.52%0.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.17 10.17 17.39 16.82 28.93
Price-to-Sales (P/S) Ratio
4.04 4.04 5.05 6.61 9.16
Price-to-Book (P/B) Ratio
1.37 1.37 2.04 2.28 3.49
Price-to-Free Cash Flow (P/FCF) Ratio
11.09 11.09 24.51 191.70 192.76
Price-to-Operating Cash Flow Ratio
10.31 10.31 13.82 38.87 14.30
Price-to-Earnings Growth (PEG) Ratio
0.43 0.43 0.00 0.55 -1.54
Price-to-Fair Value
1.37 1.37 2.04 2.28 3.49
Enterprise Value Multiple
4.91 4.91 8.55 9.32 17.10
Enterprise Value
7.75M 10.48M 15.11M 14.93M 21.14M
EV to EBITDA
4.20 4.91 8.55 9.32 17.10
EV to Sales
2.32 2.94 3.95 5.29 7.80
EV to Free Cash Flow
8.22 8.08 19.18 153.40 164.26
EV to Operating Cash Flow
7.56 7.51 10.82 31.10 12.18
Tangible Book Value Per Share
1.56 1.56 1.40 1.16 0.98
Shareholders’ Equity Per Share
1.57 1.57 1.42 1.25 1.09
Tax and Other Ratios
Effective Tax Rate
0.21 0.21 0.13 0.08 0.09
Revenue Per Share
0.54 0.54 0.57 0.43 0.41
Net Income Per Share
0.21 0.21 0.17 0.17 0.13
Tax Burden
0.83 0.79 0.87 0.93 0.92
Interest Burden
0.99 1.00 0.99 0.98 0.97
Research & Development to Revenue
0.00 0.46 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.95 0.99 1.26 0.43 2.02
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis